Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group (Q57219212)
Jump to navigation
Jump to search
scientific article published in July 2001
- Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARalpha isoforms: a study of the PETHEMA group
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group |
scientific article published in July 2001 |
|
Statements
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group (English)
0 references
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARalpha isoforms: a study of the PETHEMA group (English)
0 references
July 2001
0 references
114
0 references
1
0 references
99-103
0 references
1 reference
1 reference
1 reference